Base-Edited T Cells Could Minimize Immunotherapy Complications in Leukemia, Study Suggests
The use of base editing to generate universal, off-the-shelf CAR T cells is a promising approach for relapsed leukemia, with potential implications for the future of gene therapy.
Osimertinib Demonstrates Overall Survival Benefit as Adjuvant Lung Cancer Treatment
Osimertinib (Tagrisso; AstraZeneca) now has shown a statistically significant and clinically meaningful overall survival benefit in both the early adjuvant and late-stage metastatic settings.
2 Clarke Drive Cranbury, NJ 08512